Skip to main content

WPI 3155 Pill - white capsule/oblong

Pill with imprint WPI 3155 is White, Capsule/Oblong and has been identified as Modafinil 200 mg. It is supplied by Watson Laboratories, Inc.

Modafinil is used in the treatment of Shift Work Sleep Disorder; Obstructive Sleep Apnea/Hypopnea Syndrome; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3155

Modafinil 200 mg WPI 3155
Modafinil 200 mg WPI 3155 Front
Modafinil 200 mg WPI 3155 Back


WPI 3155
200 mg
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose monohydrate, corn starch, crospovidone, croscarmellose sodium, silicon dioxide, magnesium stearate, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3500 (Discontinued) Watson Pharmaceuticals, Inc.
42291-0600 (Discontinued) AvKare, Inc.
00904-6424 (Discontinued) Major Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.